Jyong Biotech MENS
NASDAQ MENS
$2.18 +0.15 (+7.39%)
At close: Oct 2, 2026 · 4:00 PM EDT

Jyong Biotech (MENS) Accumulated Expenses (2024 - 2025)

Updated

Jyong Biotech (MENS) recorded Accumulated Expenses of $1.04 million in the quarter ended Dec 31, 2025, down 13.2% from $1.2 million a year earlier.

Analysis

Jyong Biotech (MENS) Accumulated Expenses (2024 - 2025) Analysis & Trends

  • Across earlier years, Accumulated Expenses came in at $1.2 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Jyong Biotech 165.74 Mn 165.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.04 Mn
Jun 30, 2025 991,000.00
Dec 31, 2024 1.20 Mn
API Access

Jyong Biotech Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=MENS&period=max&api_key=YOUR_API_KEY